Modulation of Cytotoxicity by Transcription-Coupled Nucleotide Excision Repair Is Independent of the Requirement for Bioactivation of Acylfulvene.

Bioactivation as well as DNA repair affects the susceptibility of cancer cells to the action of DNA-alkylating chemotherapeutic drugs. However, information is limited with regard to the relative contributions of these processes to the biological outcome of metabolically activated DNA alkylating agents. We evaluated the influence of cellular bioactivation capacity and DNA repair on cytotoxicity of the DNA alkylating agent acylfulvene (AF). We compared the cytotoxicity and RNA synthesis inhibition by AF and its synthetic activated analogue iso-M0 in a panel of fibroblast cell lines with deficiencies in transcription-coupled (TC-NER) or global genome nucleotide excision repair (GG-NER). We related these data to the inherent bioactivation capacity of each cell type on the basis of mRNA levels. We demonstrated that specific inactivation of TC-NER by siRNA had the largest positive impact on AF activity in a cancer cell line. These findings establish that transcription-coupled DNA repair reduces cellular sensitivity to AF, independent of the requirement for bioactivation.

[1]  S. Amin,et al.  Simultaneous Detection of Deoxyadenosine and Deoxyguanosine Adducts in the Tongue and Other Oral Tissues of Mice Treated with Dibenzo[a,l]pyrene , 2014, Chemical research in toxicology.

[2]  S. Amin,et al.  Adenine-DNA adduct derived from the nitroreduction of 6-nitrochrysene is more resistant to nucleotide excision repair than guanine-DNA adducts. , 2013, Chemical research in toxicology.

[3]  S. Broyde,et al.  Adenine-DNA adducts derived from the highly tumorigenic Dibenzo[a,l]pyrene are resistant to nucleotide excision repair while guanine adducts are not. , 2013, Chemical research in toxicology.

[4]  P. V. van Midwoud,et al.  Quantification of acylfulvene- and illudin S-DNA adducts in cells with variable bioactivation capacities. , 2013, Chemical research in toxicology.

[5]  F. Johnson,et al.  Solution structure of duplex DNA containing a β-carba-Fapy-dG lesion. , 2013, Chemical research in toxicology.

[6]  S. Sturla,et al.  Chemistry and biology of acylfulvenes: sesquiterpene-derived antitumor agents. , 2012, Chemical reviews.

[7]  A. Grollman,et al.  Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam-DNA adducts , 2011, Nucleic acids research.

[8]  B. McKay,et al.  Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin , 2010, BMC Cancer.

[9]  V. Arlt,et al.  Formation and persistence of DNA adducts formed by the carcinogenic air pollutant 3-nitrobenzanthrone in target and non-target organs after intratracheal instillation in rats. , 2007, Carcinogenesis.

[10]  T. Kensler,et al.  Depurinating acylfulvene-DNA adducts: characterizing cellular chemical reactions of a selective antitumor agent. , 2007, Journal of the American Chemical Society.

[11]  P. Hanawalt,et al.  Host cell reactivation of plasmids containing oxidative DNA lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome fibroblasts. , 2006, DNA repair.

[12]  E. Raymond,et al.  Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells , 2006, Cancer Chemotherapy and Pharmacology.

[13]  T. Mcmorris,et al.  Acylfulvenes, a new class of potent antitumor agents , 1996, Experientia.

[14]  E. Raymond,et al.  Irofulven Cytotoxicity Depends on Transcription-Coupled Nucleotide Excision Repair and Is Correlated with XPG Expression in Solid Tumor Cells , 2004, Clinical Cancer Research.

[15]  M. Kelner,et al.  Enhanced Antitumor Activity of Irofulven in Combination with Antimitotic Agents , 2002, Investigational New Drugs.

[16]  Y. Pommier,et al.  Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors. , 2001, Cancer letters.

[17]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[18]  T. Buterin,et al.  Unrepaired fjord region polycyclic aromatic hydrocarbon-DNA adducts in ras codon 61 mutational hot spots. , 2000, Cancer research.

[19]  Fang Wang,et al.  An intercalated and thermally stable FAPY adduct of aflatoxin B1 in a DNA duplex: structural refinement from 1H NMR. , 1998, Biochemistry.

[20]  R. Turesky,et al.  Formation and differential removal of C-8 and N2-guanine adducts of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in the liver, kidney, and colorectum of the rat. , 1996, Chemical research in toxicology.

[21]  J. Read.  Excision repair. , 1970, The British journal of radiology.